Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay

Neoadjuvant chemotherapy (NAC) has the added advantage of increasing breast conservation rates with equivalent survival outcomes compared with adjuvant chemotherapy. A subset of breast cancer patients who received NAC experienced early failure (EF) during the course of therapy or within a short peri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Park, Kyunghee, Choi, Moon Ki, Jung, Hae Hyun, Do, In-Gu, Lee, Kwang Hee, Ahn, TaeJin, Kil, Won Ho, Kim, Seok Won, Lee, Jeong Eon, Nam, Seok Jin, Kim, Duk-Hwan, Ahn, Jin Seok, Im, Young-Hyuck, Park, Yeon Hee
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695201/
https://ncbi.nlm.nih.gov/pubmed/26009992
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares